Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health gross margin
Gross margin is gross profit as a percentage of revenue.
Aspira Women's Health's gross margin for the twelve months ending Jun 30, 2026 was 2954.7%. For fiscal 2025 it was 1724.5%, against 136975.0% the year before. The highest annual figure on record is 136975.0% in fiscal 2024.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1724.5% | −135250.5 |
| FY2024 | Dec 31, 2024 | 136975.0% | +136969.0 |
| FY2023 | Dec 31, 2023 | 6.0% | −46.8 |
| FY2022 | Dec 31, 2022 | 52.8% | +7.9 |
| FY2021 | Dec 31, 2021 | 45.0% | +18.4 |
| FY2020 | Dec 31, 2020 | 26.6% | +0.2 |
| FY2019 | Dec 31, 2019 | 26.3% | +29.2 |
| FY2018 | Dec 31, 2018 | -2.9% | −9.5 |
| FY2017 | Dec 31, 2017 | 6.6% | +8.8 |
| FY2016 | Dec 31, 2016 | -2.1% | +3.9 |
| FY2015 | Dec 31, 2015 | -6.1% | −57.3 |
| FY2014 | Dec 31, 2014 | 51.2% | −42.2 |
| FY2013 | Dec 31, 2013 | 93.4% | −0.4 |
| FY2012 | Dec 31, 2012 | 93.7% | +0.5 |
| FY2011 | Dec 31, 2011 | 93.3% | +0.8 |
| FY2010 | Dec 31, 2010 | 92.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 6652.9% | +5745.2 |
| Q1 FY2026 | Mar 31, 2026 | 3346.9% | +3286.8 |
| Q4 FY2025 | Dec 31, 2025 | 4493.8% | +4435.1 |
| Q3 FY2025 | Sep 30, 2025 | 1553.9% | +1497.5 |
| Q2 FY2025 | Jun 30, 2025 | 907.7% | +906.2 |
| Q3 FY2024 | Sep 30, 2024 | 60.0% | +1.1 |
| Q2 FY2024 | Jun 30, 2024 | 58.6% | −3.6 |
| Q1 FY2024 | Mar 31, 2024 | 56.4% | +5.2 |
| Q4 FY2023 | Dec 31, 2023 | 1.5% | −56.1 |
| Q3 FY2023 | Sep 30, 2023 | 59.0% | +3.2 |
| Q2 FY2023 | Jun 30, 2023 | 62.2% | +15.5 |
| Q1 FY2023 | Mar 31, 2023 | 51.2% | +0.4 |
| Q4 FY2022 | Dec 31, 2022 | 57.6% | +2.8 |
| Q3 FY2022 | Sep 30, 2022 | 55.8% | +10.8 |
| Q2 FY2022 | Jun 30, 2022 | 46.8% | +8.1 |
| Q1 FY2022 | Mar 31, 2022 | 50.8% | +10.5 |
| Q4 FY2021 | Dec 31, 2021 | 54.8% | +38.8 |
| Q3 FY2021 | Sep 30, 2021 | 45.0% | +10.1 |
| Q2 FY2021 | Jun 30, 2021 | 38.7% | +18.2 |
| Q1 FY2021 | Mar 31, 2021 | 40.3% | +5.9 |
| Q4 FY2020 | Dec 31, 2020 | 16.0% | −23.5 |
| Q3 FY2020 | Sep 30, 2020 | 34.9% | +8.7 |
| Q2 FY2020 | Jun 30, 2020 | 20.5% | +0.0 |
| Q1 FY2020 | Mar 31, 2020 | 34.4% | +20.9 |
| Q4 FY2019 | Dec 31, 2019 | 39.4% | +21.1 |
| Q3 FY2019 | Sep 30, 2019 | 26.1% | +26.7 |
| Q2 FY2019 | Jun 30, 2019 | 20.5% | +34.6 |
| Q1 FY2019 | Mar 31, 2019 | 13.6% | +37.3 |
| Q4 FY2018 | Dec 31, 2018 | 18.3% | +7.8 |
| Q3 FY2018 | Sep 30, 2018 | -0.5% | +10.9 |
| Q2 FY2018 | Jun 30, 2018 | -14.1% | −36.8 |
| Q1 FY2018 | Mar 31, 2018 | -23.7% | −23.6 |
| Q4 FY2017 | Dec 31, 2017 | 10.5% | +5.7 |
| Q3 FY2017 | Sep 30, 2017 | -11.4% | +19.7 |
| Q2 FY2017 | Jun 30, 2017 | 22.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -0.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 4.8% | – |
| Q3 FY2016 | Sep 30, 2016 | -31.1% | – |
See a number that looks wrong?